The Recall Desk
ModerateFDA (Drugs)·D-0456-2021·Announced 2021-06-02

Cardinal Health Recalls Synjardy Tablets Due to Temperature Excursions

Cardinal Health is recalling 284 bottles of Synjardy tablets due to intermittent temperature excursions during storage. The affected product was distributed in Florida, Georgia, and South Carolina.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific injuries or hospitalizations are reported in the source text, and the hazard is a storage condition deviation rather than a direct contamination or defect.

Plain-English summary

Cardinal Health Inc. is recalling 284 bottles of Synjardy (empagliflozin and metformin hydrochloride) Tablets 12.5 mg/1000 mg, 60 tablets per bottle. The recall is due to Current Good Manufacturing Practice (CGMP) deviations involving intermittent exposure to temperature excursions during storage.

The affected product, identified by code C80102, was distributed by Boehringer Ingleheim (BI) Pharmaceuticals, Inc. and is available in Florida, Georgia, and South Carolina. Synjardy is a prescription medication used to treat type 2 diabetes.

Consumers who have this specific product should stop using it and contact their healthcare provider or pharmacist for guidance on replacement or disposal. The recall is classified as FDA Class II, indicating a reasonable probability that the use of the product may cause temporary or medically reversible adverse health consequences.

The recalled product

Product
Synjardy (empagliflozin and metformin hydrochloride) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0168-69 Distributed by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
Affected units
284

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • C80102

Distribution

Distributed in 3 states:

Part of a larger recall action

This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 198 products in this recall →